Fig. 3

Waterfall plot for best percent change in target lesions from baseline among individual patients (n = 96). Four of 100 patients discontinued treatment before the first post-baseline imaging examination; their responses could not be assessed and were not shown in this figure. One of 96 patients had a stable disease and withdrew from the study due to personal reason without confirmation of response; the final response was deemed as not evaluable